The global phenomenon of Korean skincare merits rigorous scientific scrutiny, and the evidence reveals a landscape far more nuanced than either its most fervent proponents or dismissive critics suggest.

To examine the clinical evidence, formulation science, and regulatory context behind K-beauty ingredients and multi-step routines, offering clinicians a framework for distinguishing therapeutic potential from marketing spectacle.

Systematic review of published RCTs, controlled trials, and clinical studies for individual K-beauty ingredients including niacinamide, Centella asiatica, snail mucin, fermented filtrates, tranexamic acid, arbutin, and hyaluronic acid. Regulatory comparison across Korea (MFDS), US (FDA), and EU frameworks.

Core K-beauty principles — daily broad-spectrum photoprotection, barrier-centric hydration, and gentle cleansing — rest on solid dermatological foundations. Niacinamide (5%) and Centella asiatica have the strongest independent evidence. However, the multi-step ritual itself and many trending ingredients (mugwort, ginseng) lack controlled human evidence. Korean sunscreen formulation science objectively outpaces US options due to regulatory differences.

A streamlined regimen of 3-5 products can deliver the same benefits attributed to elaborate routines, with less risk of sensitization or barrier disruption. Consistency, gentleness, targeted active delivery, and sun protection matter far more than step count.

Provides clinicians with an evidence-graded framework for counseling patients on K-beauty ingredients and practices, distinguishing validated actives from marketing-driven trends.